Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors.

Authors

Joaquim Bellmunt

Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA

Joaquim Bellmunt , Lillian Werner , Jeffrey J. Leow , Stephanie A. Mullane , Markus Riester , Paul Van Hummelen , Jonathan E. Rosenberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2014 Genitourinary Cancers Symposium

bookmark_border

Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway and prognostic significance for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial cancer (UC).

First Author: Joaquim Bellmunt

insert_chart_outlined

Poster

2018 ASCO Annual Meeting

bookmark_border

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

First Author: Razelle Kurzrock

insert_chart_outlined

Poster

2014 ASCO Annual Meeting

bookmark_border

Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.

First Author: Daniela Adua

insert_chart_outlined

Poster

2014 Gastrointestinal Cancers Symposium

bookmark_border

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

First Author: Rachna T. Shroff